The relationship between methionine synthase rs1805087 polymorphism and hematological cancers risk

Papers of special note have been highlighted as: • of interest

References

• 1. Campbell V, Copland M. Hedgehog signaling in cancer stem cells: a focus on hematological cancers. Stem Cells Cloning 8, 27–38 (2015).
  MedlineGoogle Scholar
• 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).
  MedlineGoogle Scholar
• 3. Drokow EK, Sun K, Ahmed HAW, Akpabla GS, Song J, Shi M. Circulating microRNA as diagnostic biomarkers for haematological cancers: a systematic review and meta-analysis. Cancer Manag. Res. 11, 4313–4326 (2019).
  Medline CASGoogle Scholar
• 4. Tabe Y, Lorenzi PL, Konopleva M. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood 134(13), 1014–1023 (2019). • This article present the roles of amino acid metabolism in the immunosuppressive tumor microenvironment and in drug resistance. It also offers an argument for the reclassification of amino acid–depleting enzymes as targeted therapeutic agents.
  Medline CASGoogle Scholar
• 5. Jabagi MJ, Goncalves A, Vey N, Le Tri T, Zureik M, Dray-Spira R. Risk of hematologic malignant neoplasms after postoperative treatment of breast cancer. Cancers (Basel) 11(10), 1463 (2019).
  CASGoogle Scholar
• 6. Chiu BC, Weisenburger DD, Zahm SH et al. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 13, 525–531 (2004).
  Medline CASGoogle Scholar
• 7. Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma: a review. Acta Oncol. 45, 258–271 (2006).
  MedlineGoogle Scholar
• 8. Schiffman JD. Applying molecular epidemiology in pediatric leukemia. J. Invest. Med. 64, 355–360 (2016).
  MedlineGoogle Scholar
• 9. Segel GB, Lichtman MA. Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells Mol. Dis. 32, 246–261 (2004).
  MedlineGoogle Scholar
• 10. Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr. Clin. North Am. 62, 47–60 (2015).
  MedlineGoogle Scholar
• 11. Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62, S3–S12; discussion S13 (2004).
  MedlineGoogle Scholar
• 12. Blount BC, Mack MM, Wehr CM, MacGregor JT et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl Acad. Sci. USA 94, 3290–3295 (1997).
  Medline CASGoogle Scholar
• 13. Beetstra S, Thomas P, Salisbury C, Turner J, Fenech M. Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei. Mutat. Res. 578, 317–326 (2005).
  Medline CASGoogle Scholar
• 14. Pufulete M, Al-Ghnaniem R, Leather AJM et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 124, 1240–1248 (2003).
  Medline CASGoogle Scholar
• 15. Song MA, Brasky TM, Marian C et al. Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from heathy women. Carcinogenesis 37, 471–480 (2016). • A useful study showing that single nucleotide polymorphisms in formyltetrahydrofolate dehydrogenase and methionine synthase are associated with their own methylation is novel and highlights a role for these SNPs as methylation quantitative trait loci.
  Medline CASGoogle Scholar
• 16. Ly A, Hoyt L, Crowell J et al. Folate and DNA methylation. Antioxid. Redox Signal. 17, 302–326 (2012). • This study concluded that the progressive, dose-dependent and potentially reversible epigenetic changes observed in cancer present new opportunities in cancer risk modification and prevention using dietary and lifestyle factors.
  Medline CASGoogle Scholar
• 17. Matsuo K, Suzuki R, Hamajima N et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97, 3205–3209 (2001).
  Medline CASGoogle Scholar
• 18. Petra BG, Janez J, Vita D. Gene–gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk. Lymphoma 48, 786–792 (2007).
  Medline CASGoogle Scholar
• 19. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat. Rev. Genet. 1, 11–19 (2000). • A useful study showing that DNA methylation is directly connected to transcriptional repression through chromatin-remodeling complexes and further demonstrate that DNA methylation is important in imprinting, X-inactivation, cancer and for the developmental control of gene expression.
  Medline CASGoogle Scholar
• 20. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat. Genet. 21, 163–167 (1999). • This study provided insight on understanding of the role of DNA methylation in malignant transformation, and suggested that the Knudson's two-hit hypothesis should now be expanded to include epigenetic mechanisms of gene inactivation.
  Medline CASGoogle Scholar
• 21. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res. 60, 129–133 (2000).
  Medline CASGoogle Scholar
• 22. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in non-neoplastic gastric epithelia. Am. J. Pathol. 161, 399–403 (2002).
  Medline CASGoogle Scholar
• 23. Harmon DL, Shields DC, Woodside JV et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet. Epidemiol. 17, 298–309 (1999).
  Medline CASGoogle Scholar
• 24. Chen J, Stampfer MJ, Ma J et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 154, 667–672 (2001).
  Medline CASGoogle Scholar
• 25. Nakao H, Wakai K, Ishii N et al. Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects. BMC Gastroenterol. 16, 83 (2016).
  MedlineGoogle Scholar
• 26. Nazki FH, Sameer AS, Ganaie BA. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 533, 11–20 (2014).
  Medline CASGoogle Scholar
• 27. Bleich S, Semmler A, Frieling H et al. Genetic variants of methionine metabolism and DNA methylation. Epigenomics 6, 585–591 (2014).
  CASGoogle Scholar
• 28. Shao HB, Ren K, Gao SL et al. Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer. Aging (Albany NY) 10, 1776–1788 (2018).
  Medline CASGoogle Scholar
• 29. Akbari MT, Naderi A, Saremi L, Sayad A, Irani S, Ahani A. Methionine synthase A2756G variation is associated with the risk of retinoblastoma in Iranian children. Cancer Epidemiol. 39, 1023–1025 (2015).
  MedlineGoogle Scholar
• 30. Guo SJ, Luo SC, Liu WY, Zuo QN, Li XH. Methionine synthase A2756G polymorphism and lymphoma risk: a meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 21, 3075–3082 (2017).
  MedlineGoogle Scholar
• 31. Novotna B, Topinka J, Solansky I et al. Impact of air pollution and genotype variability on DNA damage in Prague policemen. Toxicol. Lett. 172, 37–47 (2007).
  Medline CASGoogle Scholar
• 32. Drokow EK, Chen Y, Waqas Ahmed HA et al. The relationship between leukemia and TP53 gene codon Arg72Pro polymorphism: analysis in a multi-ethnic population. Future Oncol. 16(14), 923–937 (2020).
  CASGoogle Scholar
• 33. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997).
  Medline CASGoogle Scholar
• 34. Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, Carmona-Saez P MetaGenyo: a web tool for meta-analysis of genetic association studies. BMC Bioinformatics 18, 563 (2017).
  MedlineGoogle Scholar
• 35. Rahimi Z, Rahimi Z, Ahmadian Z et al. Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from western Iran. Mol Biol Rep. 39, 2195–2000 (2012).
  Medline CASGoogle Scholar
• 36. Nikbakht M, MalekZadeh K, Kumar Jha A et al. Polymorphisms of MTHFR and MTR genes are not related to susceptibility to childhood ALL in north India. Exp. Oncol. 34, 43–48 (2012).
  Medline CASGoogle Scholar
• 37. Lightfoot TJ, Johnston WT, Painter D et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood 115, 3923–3929 (2010).
  Medline CASGoogle Scholar
• 38. Kim HN, Kim YK, Lee IK et al. Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk. Res. 33, 82–87 (2009).
  Medline CASGoogle Scholar
• 39. de Jonge R, Tissing WJE, Hooijberg JH et al. Polymorphisms in folaterelated genes and risk of pediatric acute lymphoblastic leukemia. Blood 113, 2284–2289 (2009).
  Medline CASGoogle Scholar
• 40. Gemmati D, Ongaro A, Scapoli GL et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol. Biomarkers Prev. 13, 787–794 (2004).
  Medline CASGoogle Scholar
• 41. Skibola CF, Smith MT, Hubbard A et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99, 3786–3791 (2002).
  Medline CASGoogle Scholar
• 42. Bohanec GP, Jazbec J, Dolzan V. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk. Lymphoma 48, 786–792 (2007).
  MedlineGoogle Scholar
• 43. Milne E, Greenop KR, Scott RJ et al. Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol. Biomarkers Prev. 24, 48–56 (2015).
  Medline CASGoogle Scholar
• 44. Martino A, Campa D, Jurczyszyn A et al. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations – an extensive replication of the associations from the candidate gene era. Cancer Epidemiol. Biomarkers Prev. 23, 670–674 (2014).
  Medline CASGoogle Scholar
• 45. Ruiz-Cosano J, Torres-Moreno D, Conesa-Zamora P. Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population. J. BUON 18, 486–490 (2013).
  Medline CASGoogle Scholar
• 46. How C, Hui AB, Alajez NM et al. MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PLoS One 8, e67846 (2013).
  Medline CASGoogle Scholar
• 47. Weiner AS, Beresina OV, Voronina EN et al. Polymorphisms in folate metabolizing genes and risk of non-Hodgkin's lymphoma. Leuk. Res. 35, 508–515 (2011).
  Medline CASGoogle Scholar
• 48. Gast A, Bermejo JL, Flohr T et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case–control study. Leukemia 21, 320–325 (2007).
  Medline CASGoogle Scholar
• 49. Kurzwelly D, Knop S, Guenther M et al. Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. J. Neurooncol. 100, 187–192 (2010).
  Medline CASGoogle Scholar
• 50. Berglund M, Enblad G, Turesson I et al. Folate-metabolizing genes in lymphoma patients from Sweden. Scand. J. Immunol. 70, 408–410 (2009).
  Medline CASGoogle Scholar
• 51. Lima CS, Ortega MM, Ozelo MC et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res. 32, 401–405 (2008).
  Medline CASGoogle Scholar
• 52. Kim HN, Lee IK, Kim YK et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br. J. Haematol. 140, 287–294 (2008).
  Medline CASGoogle Scholar
• 53. Lim U, Wang SS, Hartge P et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 109, 3050–3059 (2007).
  Medline CASGoogle Scholar
• 54. Lee KM, Lan Q, Kricker A et al. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum. Genet. 122, 525–533 (2007).
  Medline CASGoogle Scholar
• 55. Kim HN, Kim YK, Lee IK et al. Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. Am. J. Hematol. 82, 798–801 (2007).
  Medline CASGoogle Scholar
• 56. Niclot S, Pruvot Q, Besson C et al. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 108, 278–285 (2006).
  Medline CASGoogle Scholar
• 57. Lightfoot TJ, Skibola CF, Willett EV et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol. Biomarkers Prev. 14, 2999–3003 (2005).
  Medline CASGoogle Scholar
• 58. Skibola CF, Forrest MS, Coppede F et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104, 2155–2162 (2004).
  Medline CASGoogle Scholar
• 59. Lincz LF, Scorgie FE, Kerridge I et al. Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br. J. Haematol. 120, 1051–1054 (2003).
  Medline CASGoogle Scholar
• 60. Metayer C, Scélo G, Chokkalingam AP et al. Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 22, 1243–1258 (2011).
  MedlineGoogle Scholar
• 61. Kamel AM, Moussa HS, Ebid GT, Bu RR, Bhatia KG. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J. Egypt. Natl Cancer Inst. 19, 96–105 (2007).
  MedlineGoogle Scholar
• 62. LautnerCsorba O, Gézsi A, Erdélyi DJ et al. Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis. PLoS One 8, e69843 (2013).
  Medline CASGoogle Scholar
• 63. Gemmati D, Ongaro A, Scapoli AL et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol. Biomarkers Prev. 13, 787–794 (2004).
  Medline CASGoogle Scholar
• 64. Linneban KM, Schmidt S, Kolsch H et al. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br. J. Cancer. 90, 1969–1971 (2004).
  MedlineGoogle Scholar
• 65. Gra OA, Glotov AS, Kozhekbaeva Z, Makarova OV, Nasedkina TV. Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol. Biol. 42, 214–225 (2008).
  CASGoogle Scholar
• 66. Gra OA, Glotov AS, Nikitin EA et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am. J. Hematol. 83, 279–287 (2008).
  Medline CASGoogle Scholar
• 67. Yang L, Liu L, Wang J et al. Polymorphisms in folate-related genes: Impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leuk. Lymphoma 52, 1770–1776 (2011).
  Medline CASGoogle Scholar
• 68. Amigou A, Rudant J, Orsi L et al. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control. 23, 1265–1277 (2012).
  MedlineGoogle Scholar
• 69. Suthandiram S, Gan GG, Mohd Zain S et al. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. Tumor Biol. 36, 1819–1834 (2015).
  Medline CASGoogle Scholar
• 70. Hui L, Shao-Yan H, Zhi-Zuo D et al. Gene polymorphisms in the folate metabolic pathway and risk of pediatric acute lymphoblastic leukemia: a case-control study in a Chinese population. Int. J. Clin. Exp. Pathol. 11(3), 1724–1731 (2018).
  MedlineGoogle Scholar
• 71. Xiaolei L, Shunguo Z, Feng Y. Rs4846049 polymorphism at the 39-UTR of MTHFR gene: association with susceptibility to childhood acute lymphoblastic leukemia. BioMed Research International Article ID 4631091, 12 (2019).
  Google Scholar
• 72. Li-Min M, Hai-Ping Y, Xue-Wen Y, Lin-Hai R Methionine synthase A2756G polymorphism influences pediatric acute lymphoblastic leukemia risk: a meta-analysis. Bioscience Reports 39, BSR20181770 (2019).
  Google Scholar
• 73. Davidsson J, Lilljebjörn H, Andersson A et al. The DNA methylome of pediatric acute lymphoblastic leukemia. Hum. Mol. Genet. 18, 4054–4065 (2009).
  Medline CASGoogle Scholar
• 74. Mullighan CG. Genomic characterization of childhood acute lymphoblastic leukemia. Semin. Hematol. 50, 314–324 (2013).
  Medline CASGoogle Scholar
• 75. He J, Wang F, Zhu JH, Chen W, Cui Z, Jia WH. No association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjects. Leuk. & Lymphoma 56(3), 763–777 (2015).
  Medline CASGoogle Scholar
• 76. Zeng X, Lu J, Tang X, Weng H, Luo J. Association of methionine synthase rs1801394 and methionine synthase reductase rs1805087 polymorphisms with meningioma in adults: A meta-analysis. Biomedical Reports 2(3), 432–436 (2014).
  Medline CASGoogle Scholar
• 77. Xia J, Wang Y, Zhang H, Hu Y. Association between MTR A2756G polymorphism and childhood acute lymphoblastic leukemia: a meta-analysis. Leuk. Lymphoma 55, 1388–1393 (2015).
  Google Scholar
• 78. Bing W, Kang L, Jun-Ping Y, Yan H, Jun Z, Jun-Xiang H The association between methionine synthase A2756G polymorphism and hematological cancer: a meta-analysis. Medicine 96, 48 (2017).
  Google Scholar